Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

Phase 4 Unknown 133 enrolled Guangdong Provincial People's Hospital

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is an extended follow-up of the study (ClinicalTrials.gov ID: NCT01758120)-Treatment of prednisone plus cyclophosphamide may be superior to treatment of prednisone alone in patients with advanced-stage IgA nephropathy.

Timeline

Start: 2016-12
Primary completion: 2021-12
Completion: 2021-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cyclophosphamide	Other / unclassified	1 g	Intravenous
Background	Prednisone	Other / unclassified	0.5 mg/kg	—

Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

Summary

Timeline

Drugs

Indications